Invenomic Capital Management LP Has $2.98 Million Stock Position in American Vanguard Co. (NYSE:AVD)

Invenomic Capital Management LP reduced its holdings in shares of American Vanguard Co. (NYSE:AVD) by 9.7% in the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 643,092 shares of the basic materials company’s stock after selling 69,304 shares during the quarter. Invenomic Capital Management LP owned 2.23% of American Vanguard worth $2,978,000 at the end of the most recent reporting period.

Other hedge funds have also recently made changes to their positions in the company. Price T Rowe Associates Inc. MD boosted its holdings in American Vanguard by 3.3% during the fourth quarter. Price T Rowe Associates Inc. MD now owns 69,909 shares of the basic materials company’s stock worth $324,000 after purchasing an additional 2,221 shares during the last quarter. Wells Fargo & Company MN boosted its holdings in American Vanguard by 23.8% during the fourth quarter. Wells Fargo & Company MN now owns 14,952 shares of the basic materials company’s stock worth $69,000 after purchasing an additional 2,875 shares during the last quarter. Gabelli Funds LLC boosted its holdings in American Vanguard by 15.8% during the fourth quarter. Gabelli Funds LLC now owns 22,000 shares of the basic materials company’s stock worth $102,000 after purchasing an additional 3,000 shares during the last quarter. PNC Financial Services Group Inc. boosted its holdings in American Vanguard by 133.0% during the fourth quarter. PNC Financial Services Group Inc. now owns 6,575 shares of the basic materials company’s stock worth $30,000 after purchasing an additional 3,753 shares during the last quarter. Finally, Northern Trust Corp boosted its holdings in American Vanguard by 3.3% during the fourth quarter. Northern Trust Corp now owns 224,507 shares of the basic materials company’s stock worth $1,039,000 after purchasing an additional 7,251 shares during the last quarter. 79.04% of the stock is currently owned by institutional investors and hedge funds.

American Vanguard Stock Up 1.6%

AVD opened at $4.46 on Monday. The company has a quick ratio of 0.79, a current ratio of 1.89 and a debt-to-equity ratio of 0.55. The stock has a market cap of $128.39 million, a price-to-earnings ratio of -4.33 and a beta of 1.24. American Vanguard Co. has a twelve month low of $3.28 and a twelve month high of $9.84. The company’s 50-day moving average price is $4.24 and its two-hundred day moving average price is $4.98.

Wall Street Analyst Weigh In

Separately, Lake Street Capital set a $14.00 price target on shares of American Vanguard in a report on Tuesday, January 21st.

American Vanguard Company Profile

American Vanguard Corporation, through its subsidiaries, develops, manufactures, and markets specialty chemicals for agricultural, commercial, and consumer uses in the United States and internationally. It manufactures and formulates chemicals, including insecticides, fungicides, herbicides, soil health, plant nutrition, molluscicides, growth regulators, soil fumigants, and biorationals in liquid, powder, and granular forms for crops, turf and ornamental plants, and human and animal health protection.